| PSMD14 |
PSMD14, POH1: 26S proteasome non-ATPase regulatory subunit 14 |
RAD23B |
RAD23B: UV excision repair protein RAD23 homolog B |
0.512 |
Evidence |
|
| PSMD14 |
PSMD14, POH1: 26S proteasome non-ATPase regulatory subunit 14 |
USP14 |
USP14, TGT: Ubiquitin carboxyl-terminal hydrolase 14 |
0.512 |
Evidence |
O
|
| PSMD14 |
PSMD14, POH1: 26S proteasome non-ATPase regulatory subunit 14 |
PSMB2 |
PSMB2: Proteasome subunit beta type-2 |
0.512 |
Evidence |
O
|
| PSMD14 |
PSMD14, POH1: 26S proteasome non-ATPase regulatory subunit 14 |
HARS |
HARS, HRS: Histidyl-tRNA synthetase, cytoplasmic |
0.512 |
Evidence |
O
|
| RANBP5 |
|
RP11-196G18.6 |
HIST2H2BF: Histone H2B type 2-F |
0.512 |
Evidence |
|
| RANBP5 |
|
FBL |
FBL, FIB1, FLRN: rRNA 2'-O-methyltransferase fibrillarin |
0.512 |
Evidence |
|
| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
TRIP10 |
TRIP10, CIP4, STOT, STP: Cdc42-interacting protein 4 |
0.512 |
Evidence |
|
| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
PLS3 |
Plastin 3 variant (Fragment) |
0.512 |
Evidence |
|
| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
MYO1E |
IPI00619954 |
0.512 |
Evidence |
|
| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
SH3YL1 |
IPI00395699 |
0.512 |
Evidence |
|
| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
NEDD4L |
IPI00304945 |
0.512 |
Evidence |
|
| CDC7 |
CDC7, CDC7L1: Cell division cycle 7-related protein kinase |
RPS27A |
IPI00554749 |
0.512 |
Evidence |
|
| CDC7 |
CDC7, CDC7L1: Cell division cycle 7-related protein kinase |
STIP1 |
STIP1: STIP1 protein |
0.512 |
Evidence |
|
| PSMD12 |
PSMD12: 26S proteasome non-ATPase regulatory subunit 12 |
VPS13A |
|
0.512 |
Evidence |
|
| PSMD12 |
PSMD12: 26S proteasome non-ATPase regulatory subunit 12 |
IQGAP3 |
IQGAP3: Uncharacterized protein IQGAP3 |
0.512 |
Evidence |
|
| AP3B1 |
AP3B1, ADTB3A: AP-3 complex subunit beta-1 |
COG6 |
COG6, KIAA1134: Conserved oligomeric Golgi complex component 6 |
0.512 |
Evidence |
|
| AP3B1 |
AP3B1, ADTB3A: AP-3 complex subunit beta-1 |
STX16 |
STX16: Syntaxin-16 |
0.512 |
Evidence |
|
| MYH10 |
MYH10: Myosin-10 |
ACTA1 |
ACTA1, ACTA: Actin, alpha skeletal muscle |
0.512 |
Evidence |
|
| AP1G2 |
AP1G2: AP-1 complex subunit gamma-2 |
ENTH |
CLINT1, ENTH, EPN4, EPNR, KIAA0171: Clathrin interactor 1 |
0.512 |
Evidence |
|
| SYNJ1 |
SYNJ1, KIAA0910: Synaptojanin-1 |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
0.512 |
Evidence |
|
| CFDP1 |
CFDP1, BCNT: Craniofacial development protein 1 |
PSMA3 |
PSMA3, PSC8: Proteasome subunit alpha type-3 |
0.512 |
Evidence |
|
| CFDP1 |
CFDP1, BCNT: Craniofacial development protein 1 |
CLTC |
CLTC, CLH17, CLTCL2, KIAA0034: Clathrin heavy chain 1 |
0.512 |
Evidence |
|
| CFDP1 |
CFDP1, BCNT: Craniofacial development protein 1 |
VDP |
DKFZp451D234: Putative uncharacterized protein DKFZp451D234 |
0.512 |
Evidence |
|
| BRMS1 |
BRMS1: Breast cancer metastasis-suppressor 1 |
LSM2 |
LSM2, C6orf28, G7b: U6 snRNA-associated Sm-like protein LSm2 |
0.512 |
Evidence |
|
| BRMS1 |
BRMS1: Breast cancer metastasis-suppressor 1 |
DAXX |
DAXX, BING2, DAP6: Death domain-associated protein 6 |
0.512 |
Evidence |
|